Australian Electric Utilities Stock News

ASX:HGO
ASX:HGOMetals and Mining

Assessing Hillgrove Resources (ASX:HGO) Valuation After High‑Grade Copper Update And Insider Share Buying

Why Hillgrove Resources (ASX:HGO) is back on investor radar Recent confirmation of high-grade copper at the Emily Star deposit, together with increased insider share buying, has refocused attention on Hillgrove Resources as the company pursues expansion at its Kanmantoo Copper mine. See our latest analysis for Hillgrove Resources. The recent copper results and insider buying come against a backdrop of strong share price momentum, with a 52.78% 1 month share price return and a 57.14% 3 month...
ASX:MND
ASX:MNDConstruction

Monadelphous Group (ASX:MND) Is Up 10.5% After New A$300m Rio Tinto Contract Win

Monadelphous Group has secured a five-year, A$300 million maintenance contract from Rio Tinto in the Pilbara, extending a relationship that spans more than three decades. This long-term award deepens Monadelphous’ role as a key maintenance partner to tier-one miners, reinforcing the visibility of work with blue-chip clients. We’ll now examine how this new A$300 million Rio Tinto maintenance contract influences Monadelphous’ investment narrative and revenue visibility. We've found 12 US...
ASX:QBE
ASX:QBEInsurance

Did Strong 2024 Results and Reaffirmed 2025 Guidance Just Shift QBE's (ASX:QBE) Investment Narrative?

QBE Insurance Group recently reported that 2024 delivered strong profitability, with an improved combined operating ratio, solid investment income, and management reaffirming 2025 guidance for mid-single-digit premium growth and a combined operating ratio near the low 92% range. Alongside this, QBE highlighted its over 40-year sponsorship of the Sydney Swans and ongoing focus on capital management, including dividends and share buybacks, underlining the insurer’s emphasis on brand strength...
ASX:CUV
ASX:CUVBiotechs

Does Clinuvel’s New VLRX-L Injectable Platform Shift the Long-Term Pipeline Narrative for ASX:CUV?

Clinuvel Pharmaceuticals has recently begun dosing in a preclinical study of its VLRX-L controlled-release liquid injectable peptide platform, marking the first formal evaluation of this next-generation delivery technology. This step signals an effort to build a broader pipeline based on in-house intellectual property that could diversify the business beyond its existing treatment franchise if development progresses successfully. We’ll now explore how advancing the proprietary VLRX-L...
ASX:LOV
ASX:LOVSpecialty Retail

Is Canaccord’s Upgrade Reframe of Lovisa (ASX:LOV) a Turning Point in Its Expansion Strategy?

In recent days, Canaccord Genuity upgraded Lovisa Holdings from Hold to Buy, pointing to a more attractive risk‑reward profile supported by confidence in fiscal 2027 earnings. The broker highlighted that Lovisa’s expanded store rollout plans and potential operating cost efficiencies could underpin its longer-term earnings potential, despite ongoing concerns around cost growth and modest comparable store sales. We’ll now examine how Canaccord’s upgrade, anchored in Lovisa’s accelerated store...
ASX:SKS
ASX:SKSElectrical

ASX Penny Stocks Under A$500M Market Cap: 3 Promising Picks

The Australian market today presents a mixed outlook, with the Aussie dollar inching closer to 67 cents against the USD and equities poised for a flat opening. For investors interested in exploring beyond well-known names, penny stocks—typically smaller or newer companies—offer intriguing possibilities. Despite the term's outdated feel, these stocks can still provide surprising value when backed by solid financials, offering potential for significant returns and stability.